Healing hearts, one molecule at a time

We cut a finger and the skin heals. But what if hearts could heal too?

Researchers in Israel recently found a molecule in newborns that might help, some day. The team at the Weizmann Institute of Science have identified a molecule found in newborns that appears to control the renewal process, assisting regeneration in damaged hearts, according to a study published in Nature early this month.

The team is looking at how the molecule, Agrin, could treat MI victims. Agrin seems to unlock the renewal process, enabling the repair of heart muscle. In MI, cardiomyocytes are replaced with scar tissue that does not contract or pump. But the team, led by Eldad Tzahor, an associate professor, is working on a treatment that would naturally regenerate damaged tissue.

With a single injection into a mouse that had suffered a heart attack, damaged muscle began to heal completely in about a month, allowing full function. Over time, living heart tissue replaced scar tissue. Like human fetuses, mice hearts can regenerate and repair—until the mouse is about a week old. The team speculates that Agrin also affects the body's inflammatory and immune responses to a heart attack and the pathways that suppress scarring.

"Clearly this molecule sets a chain of events in motion," Tzahor said in a statement. "We discovered that it attaches to a previously unstudied receptor on the heart muscle cells, and this binding takes the cells back to a slightly less mature state—closer to that of the embryo—and releases signals that may, among other things, initiate cell division."

Pre-clinical studies in larger animals are underway in Germany.

Baby steps, for sure—but stay tuned.

 

Mary Tierney
Mary C. Tierney, MS, Vice President & Chief Content Officer, TriMed Media Group

Mary joined TriMed Media in 2003. She was the founding editor and editorial director of Health Imaging, Cardiovascular Business, Molecular Imaging Insight and CMIO, now known as Clinical Innovation + Technology. Prior to TriMed, Mary was the editorial director of HealthTech Publishing Company, where she had worked since 1991. While there, she oversaw four magazines and related online media, and piloted the launch of two magazines and websites. Mary holds a master’s in journalism from Syracuse University. She lives in East Greenwich, R.I., and when not working, she is usually running around after her family, taking photos or cooking.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.